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AbstrACt
Introduction Patellar tendinopathy is a degenerative 
disease of the patellar tendon, which affects athletes from 
a variety of sports, and is especially predominant in sports 
involving high- impact jumping. The aim of this study is 
to determine the additional effect of two interventions 
combined with eccentric exercise and compare which one 
is the most effective at short- term and long- term follow- up 
for patients with patellar tendinopathy.
Methods and analysis This study is a randomised 
controlled trial with blinded participants. Measurements 
will be carried out by a specially trained blinded assessor. 
A sample of 57 patients with a medical diagnosis of 
patellar tendinopathy will participate in this study and 
will be divided into three treatment groups. Eligible 
participants will be randomly allocated to receive either: 
(a) treatment group with percutaneous needle electrolysis, 
(b) treatment group with dry needling or (c) treatment 
group with placebo needling. In addition, all groups will 
perform eccentric exercise. Functionality and muscle 
strength parameters, pain, ultrasound appearances and 
patient perceived quality of life shall be evaluated using 
the Victorian Institute of Sports Assessment for patellar 
(VISA- P), jump tests, Visual Analogue Scale, ultrasound 
images and Short Form-36 (SF-36), respectively. 
Participants will be assessed at baseline, at 10 weeks 
and at 22 weeks after baseline. The expected findings will 
allow us to advance in the treatment of this injury, as they 
will help determine whether a needling intervention has 
additional effects on an eccentric exercise programme and 
whether any of the needling modalities is more effective 
than the other.
Ethics and dissemination This protocol has been 
approved by the Ethics Committee of Aragon (N° 
PI15/0017). The trial will be conducted in accordance with 
the Declaration of Helsinki.
trial registration number NCT02498795
IntroduCtIon
Patellar tendinopathy (PT), also known as 
jumper’s knee, is a degenerative condition 
affecting the patellar tendon resulting in 
anterior knee pain associated with focal and 
palpable tenderness at the inferior pole of the 
patella. This disorder has similar histological 
findings to other tendon disorders character-
ised by an increased thickness of the tendon 
and changes in vascularity and cellularity, 
with incompletely healed tendon microrup-
tures and disturbed collagen distribution.1
This degenerative condition affects athletes 
from a variety of sports, and is especially 
predominant in sports involving high- impact 
jumping. The overall prevalence of PT in 
non- elite players is 8.5%, although this figure 
increases in sports that place high demands on 
the patellar ligament, increasing up to 14.2% 
in volleyball athletes. Among elite volleyball 
and basketball players, a prevalence of 45% 
and 32%, respectively, has been reported. 
In addition, jumper’s knee is almost twice 
as common among male non- elite athletes 
when compared with female athletes.2
The diagnosis is typically based on the 
clinical history and symptomatic findings. 
Currently, imaging techniques, such as color- 
Doppler ultrasound (CD- US) and grey scale 
ultrasound (GS- US) can be used for the 
assessment of the patellar tendon to clinically 
confirm the diagnosis.3
Treatments used for PT fall into two major 
groups. The first group comprises medical 
treatments which include non- steroidal anti- 
inflammatory drugs (NSAIDs), platelet- rich 
strengths and limitations of this study
 ► This randomised clinical trial will report the effects 
on functionality and pain of three different treatment 
interventions in both the short- term and long- term.
 ► The double- blinded and placebo- control design will 
enhance objectivity and help reduce bias.
 ► The effects of two minimally invasive treatments in 
physical therapy will be compared for the first time 
in patellar tendinopathy.
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plasma (PRP) injection4 and autologous growth factors.5 
The second group consists of physical therapies, including 
both conservative and invasive approaches (needling 
techniques).
Conservative therapies are generally accepted as the first 
line of approach for managing PT,6 7 considering exercise 
as the gold standard of treatment, either eccentric exer-
cise (EE) or high slow resistance training programmes. 
Both have demonstrated similar effectiveness in the treat-
ment of PT.6–8 In 2012, EE was shown to be effective in the 
treatment of tendinopathies at various locations of the 
body, including PT, with a greater likelihood of clinical 
improvement when performed on a declined surface.6 8 9 
In recent years, further evidence now supports the fact 
that exercise is more effective than other conventional 
treatments in tendinopathy, such as iontophoresis, ultra-
sound (US), Cyriax treatment, etc.10
Physical therapy approaches for PT continue to evolve 
and a number of innovative treatment options are now 
available, such as dry needling (DN),11 electrotherapeutic 
invasive modalities (eg, electrolysis)12–14 and extracorpo-
real shockwave therapy.15 Recently, research has focussed 
on regenerative therapies with high expectations of 
success because some of these techniques seem to achieve 
a rapid regeneration of the injured tendon.11 12 16 However, 
evidence- based regenerative therapies are limited and 
there is no agreement to date regarding which of these 
is the most effective.17 DN consists of the insertion of a 
needle (filiform and solid, non- bevelled) with the aim 
of provoking a local injury leading to an inflammatory 
response and the subsequent regeneration of the injured 
area in approximately 1 week. A study performed by Abat 
et al reported that DN induced histological and mechan-
ical changes in rat Achilles tendons at week 1, with 
changes persisting at week 4.18 Percutaneous needle elec-
trolysis (PNE) is an ultrasound- guided technique used by 
physiotherapists consisting of causing localised lysis in the 
damaged and/or degenerated tissue by means of a galvanic 
current transmitted through an acupuncture needle. This 
technique may affect inflammatory mediators in damaged 
muscle tissue and influence the new vascularisation of the 
injured area in rats.18 James et al11 carried out a cohort 
study in humans analysing one group treated with DN 
and another treated with autologous blood injections. In 
both cases, they found improvements compared with the 
baseline measurements. However, this study failed to find 
differences between the different treatments, concluding 
that both techniques were equally effective. In relation 
to PNE, a former study14 analysed the treatment effect 
of electrolysis applied once a week in a group of patients 
without any control or comparative group, reporting that 
patients obtained statistically and clinically significant 
improvements compared with baseline measurements.
From a biological point of view, it seems reasonable 
to hypothesise that a patient will obtain benefits thanks 
to the mechanical effects provided by the needle,16 and 
that patients may benefit more if the electrolysis effect is 
added to the mechanical stimuli provided by the needle.19
Therefore, the aim of this study is to determine the 
additional effect of two interventions combined with EE 
and compare which one is the most effective at short- term 
and long- term follow- up for patients with PT.
MEthods And AnAlysIs
study design
The trial is designed as a randomised, controlled, partic-
ipant, investigator and outcomes assessor blinded, 
experimental study, aimed at comparing three different 
physiotherapy protocols applied in three intervention 
groups of PT patients. Randomisation will be performed 
as block randomisation with a 1:1:1 allocation.
This protocol follows the standards of the Helsinki 
Convention of good clinical practices. The Ethics 
Committee of Aragon (CEICA) has evaluated the project 
and has given its favourable opinion and support, N° 
PI15/0017 (online supplementary appendix 1).
The study has been carried out following the Standard 
Protocol Items: Recommendations for Interventional 
Trials (SPIRIT) statement for clinical trial protocol and a 
SPIRIT Checklist has been included (online supplemen-
tary appendix 2).
study setting
After reviewing the literature and observing the high inci-
dence of this pathology in amateur young adult athletes 
who perform sports and more specifically, jump sports, 
patient recruitment has been performed in basketball, 
football, volleyball, CrossFit and handball sports clubs, 
together with running clubs and several gyms located 
in the city. A decision was made to conduct the study 
in Villanueva de Gallego (Zaragoza), where San Jorge 
University is located, as well as the laboratory to be used 
for assessments and treatments.
The assessments will be conducted at the Motion Anal-
ysis laboratory of San Jorge University, and the treatment 
will be performed at two different sites depending on the 
availability of both spaces and of schedules. Nonetheless, 
the same material will always be used.
Participants
Inclusion criteria
Participants eligible for inclusion in this study must meet 
the following criteria: (1) History of PT and anterior knee 
pain located on the inferior pole of the patella for over 
3 months, (2) Aged between 18 and 45 years, (3) Palpa-
tion tenderness of the superior insertion of the patellar 
tendon, (4) A score below 80 on the Victorian Institute of 
Sports Assessment for PT (VISA- P) questionnaire.
Exclusion criteria
Exclusion criteria for the study are: (1) Knee surgery 
within the previous 6 months, (2) Chronic joint diseases, 
(3) Corticosteroid injection in the patellar tendon 
within the previous 3 months, (4) Contraindications 
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for needling, (5) Use of drugs 48 hours previously (eg, 
NSAIDs), (6) Any other concomitant treatment for PT.
Methodology
In the first session, all participants will be instructed on 
how to perform a daily home programme of EE. This 
will consist of performing three sets of 15 single leg squat 
repetitions on a decline board every day, according to 
Alfredson’s protocol20 increasing the speed if partici-
pants do not have pain. Participants will be informed that 
exercise is allowed to reach 5 in a numerical pain rating 
scale,21 and if it is higher then they will stop and notify 
the researcher, attempting once again 24 hours later 
following the same rules.
For the interventions, the participants will be placed in 
a supine position with a pillow under the knee (approx-
imately 20° of knee flexion). The area will be cleansed 
with an antiseptic solution (70% Propan-2- ol, Skin- des). 
An ultrasound probe cover will be used during the inter-
vention for infectious control. To determine the rele-
vant treatment area, two factors will be considered: (1) 
Palpation of the areas exhibiting higher sensitivity and 
that reproduce the patient’s symptoms, (2) Tendon areas 
showing degenerative changes assessed under ultrasound. 
Each group will receive a total of four sessions distributed 
throughout 8 weeks of treatment, once every 2 weeks.
DN intervention combined with EE and PNE intervention combined 
with EE
Specific DN needles will be used during needling treat-
ments, (Agu Punt, Spain). Considering the thickness 
of the tendon and the approach, we shall use needles 
measuring 0.25×25 mm. The procedure will be guided by 
US to ensure the specificity of application on the injured 
area and to guarantee that the procedure is safe for the 
patient. The DN needle will reach the relevant treatment 
area (areas with degenerative PT changes). Each session 
will consist of three needle insertions lasting 3 seconds 
each. In percutaneous needle electrolysis group (PNE- G) 
applications, an intensity of 3 mA galvanic current will 
be used during the 3 seconds that the procedure lasts.19 
The dose of 3 mA has demonstrated to be as effective as 
6 mA in the treatment of tendinopathy injuries in animal 
models.18 19 In humans, a study conducted in 2016 showed 
that a dose of 3 mA in PT generated structural changes 
compatible with tendon regeneration, together with 
improvement of functionality and pain.22 In contrast, the 
same study found that lower doses were effective only for 
the improvement of functionality and pain. As a result, a 
3 mA dose was selected for this study.
Control group
A sham needle will be placed on the treatment zone, 
simulating the same procedure as the rest of participants 
enrolled in the other groups. The needle will be placed 
in a specific holder and will be manipulated during the 
intervention to simulate a real treatment. This holder will 
have a cover over the bottom part of the same in order to 
avoid the needle contacting the skin.
outcomes
Baseline data
Baseline data will include gender, age, height, weight, 
body mass index, affected side, level, sports and frequency 
of physical activity, duration of symptoms, medication 
and previous rehabilitation treatments and infiltrations 
received. A blinded observer will assess all participants at 
baseline, 10 weeks and 22 weeks after baseline. Partici-
pants will be asked to inform the researchers if there were 
any changes in medication or if they are receiving any 
other treatment or infiltration during the study.
Primary outcome measure
Participants will complete the VISA- P questionnaire 
at baseline. The VISA- P questionnaire is designed to 
measure the severity of PT.23 The VISA- P score is the 
primary outcome variable. This scale consists of eight 
questions, the first six questions of which employ an 
analogical visual scale in order to assign a score of 0 to 10, 
where 10 represents the optimum state, for the purpose 
of quantifying pain and function in different activities, 
whereas the last two questions assess the level of function-
ality and ability to perform physical activity.
Secondary outcome measure
During the first evaluation, participants will complete 
the Visual Analogue Scale (VAS), considering the level 
of pain they feel while practicing their sport’s activity. 
Participants will be explained that a score of 0 indicates 
the absence of pain whereas a score of 10 represents the 
maximum tolerable pain. They will also complete a ques-
tionnaire to assess their quality of life (Short Form-36 
questionnaire (SF-36)).24
In order to assess tendon structure, an US evaluation 
using ultrasound equipment (Logiq S7 Expert, General 
Electric Healthcare) and a linear probe (MLG-15 5 to 
10 MHz) will be used. The ultrasonographic assessment 
protocol will be carried out according to the Musculo-
skeletal Ultrasound Technical Guidelines: Knee, defined 
by the European Society of Musculoskeletal Radiology.25 
The ultrasonographic assessment will consist of a longi-
tudinal sequence from the tendon origin to the inser-
tion and transverse sections on the pole of the patella, 
the tendon body and its insertion on the tibial tuberosity, 
with the subject in supine position, with 20° knee flexion 
and a pillow under the knee. The presence of degener-
ative signs compatible with the medical diagnosis of PT 
(thickness of the tendon, hypoechoic areas, irregularities 
affecting the cortical bone, calcifications) that could be 
relevant for the selection of the target area will also be 
assessed. In addition, CD- US assessment will be carried 
out to detect the presence of hypervascularisation, with 
the subject in supine position and with the knee relaxed 
in full extension, in order to obtain further information 
to specifically define the target area.
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Table 1 Jump test’s protocol
Jump test protocol
5 min warm up consisting of steady jogging on a treadmill
Dynamic stretches lasting 
5 min, as instructed by 
the physical therapist
Psoas
Quadriceps
Gluteus maximus
Gastrocnemius
Hamstring muscles
Three jump tests are 
performed
 ► Three jumps off the 
ground for three times 
for the patient to 
become familiar with 
the tests
 ► The subject is placed 
on the platform and 
asked to perform each 
test three times, with 
60 s rest between the 
different tests
Abalakov test
Countermovement jump test
Squat jump
The highest jump is selected for the study.
Figure 1 Flow diagram. Randomised controlled trial design. 
G- DN,dry needle group; G- PNE, percutaneous needle 
electrolysis group.
Figure 2 Schedule for the enrolment and intervention. 
Schedule for enrolment and intervention per cluster. 
G- DN,dry needle group; G- PNE, percutaneous needle 
electrolysis group; -t1, baseline; t1–t2, intervention period; 
T2, 8 weeks after baseline; t3, afterbaseline; T3, 10 weeks 
after baseline; t4, afterbaseline; T4, 3 months after baseline; 
US, ultrasound;VAS, Visual Analogue Scale.
On completion of the evaluation, a jump test will be 
carried out, measured with a force platform (FP4060-10-
2000, Bertec Corporation). In this evaluation, subjects will 
warm up during 5 minutes on a treadmill, subsequently, 
they will perform dynamic stretches for the leg muscles. 
The jump test will be explained to participants and they 
will be asked to demonstrate how they will perform the 
assessment to ensure that they have understood it before 
going to the platform. Later, patients will go to the plat-
form forces and will perform each jump three times 
(squat jump, Abalakov jump and countermovement 
jump test) with 60 seconds between jumps and 2 minutes 
between different jumps (table 1).26–28 The maximum 
height of the jump will be analysed via the measurement 
of the flight time recorded on the force platforms, the 
eccentric power and the maximum concentric force 
performed. The Abalakov jump will be performed with 
the subject standing in an upright position with a full arm 
swing. A rapid downward movement will be immediately 
followed by a rapid upward vertical movement as high as 
possible, all in one sequence. The same procedure will 
be applied for the countermovement jump, however, this 
test will be performed with the hands on the hips to avoid 
arm swings. Finally, a squat jump will be performed with 
90 degrees of flexion of the knee.
Participant timeline
The study design will be a double- blind randomised 
controlled trial. The flow chart of the trial is shown in 
figure 1 and the check list SPIRIT schedule is shown in 
figure 2.
Patient and public involvement
Patients with PT were not involved in setting the research 
question or the outcome measures, however the concept 
of patient involvement translated to the execution phases 
of the research. Patients and their families were central 
to the dissemination of the information, which helped to 
recruit study participants. We intend to disseminate the 
main results to trial participants and will seek patient and 
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public involvement in the development of an appropriate 
method of dissemination.
sample size
Regarding the sample size, a calculation of statistical 
power was made prior to the study. Accepting an alpha 
risk of 0.05 and a beta risk in a bilateral contrast, 19 
subjects are needed in every treatment group to detect a 
difference equal or superior to 15 points on the VISA- P 
scale and assuming a SD of 15 points.29 The estimated 
rate of loss to follow- up is 20%.
Recruitment of subjects for the trial will take place 
between October 2018 and March 2020 and will be 
carried out by means of informative campaigns targeted 
at different Sports Clubs and Federations by means of 
email and advertisements in the different University mass 
media.
The interested subjects will receive an email explaining 
the inclusion and exclusion criteria, as well as the purpose 
of the study. If they meet the defined criteria, they will be 
invited to send us their medical diagnosis.
recruitment
Participants will be recruited from sports clubs by the 
physiotherapist or the coach. Contact has been made with 
various orthopaedists who will collaborate with recruit-
ment, so that when they establish a diagnosis of this 
pathology in their examination room they can refer us to 
the patients for their recruitment to the study.
Allocation
Participants will be randomly assigned to either control 
group (CG) or dry needle group (DN- G) or PNE- G with 
a 1:1:1 allocation using an opaque envelope, with a block 
size of 15 participants (five for each group).
Sealed opaque randomisation envelopes with a study- 
specific participant number will be supplied by an external 
statistician. A colleague not involved in the research 
study will take the sealed opaque numbered envelopes 
in order, by number and deliver the correct envelope to 
the treating physical therapist. The envelope will contain 
a piece of paper, which will be labelled with the same 
participant specific number, plus the group assignment 
(PNE- G, DN- G or CG).
Participants who fulfil the inclusion criteria will receive 
the standardised oral and written information, and, once 
they grant their consent to take part in the trial, they will 
be randomised into the three groups.
blinding
Assessments regarding clinical recovery will be conducted 
by an assessor blinded to treatment allocation. Due to the 
nature of the intervention, participants can be blinded 
to allocation. Patients will be explained that they are 
going to receive a needling treatment, that it may be 
slightly painful and that if at any time they are unable 
to tolerate the pain they must inform the researcher to 
stop the intervention. In order to blind patients, all the 
interventions were made with the ultrasound and the 
PNE device connected to simulate the same intervention 
in all groups. In contrast, the physiotherapist performing 
the intervention cannot be blinded, however he/she will 
be instructed not to disclose the allocation status of the 
participant at any time or during the follow- up assess-
ments. An employee outside the research team will feed 
data into the computer in separate data sheets so that 
the researchers can analyse data without having access to 
information about the allocation.
With the intention of evaluating patient blinding, 
an online questionnaire will be sent to participants on 
completion of the study, asking them about the treatment 
they received.
data collection methods
For the data collection, an oral questionnaire will be used 
containing questions targeted at collecting baseline data 
and information concerning the pathology.
Different questionnaires and assessment scales (VISA- P, 
VAS, SF-36) in Spanish will be given to each participant in 
paper when they attend the assessment, and they will be 
granted sufficient time to complete the same.
data management and statistical analysis
In this study, all data will be entered electronically in the 
assessment room.
Original scales and questionnaires will be entered and 
kept on a locked file at the participating site.
Participant files are to be stored in numerical order 
and stored in a secure and accessible place and manner. 
Participant files will be maintained in storage for a period 
of 2 years after completion of the study.
The statistical analysis will be carried out by an 
intention- to- treat analysis. Variables will be described in 
number (percentage) and average (SD) or median (IQR) 
attending to their distribution. Quantitative variables will 
be analysed with the Shapiro- Wilk test in order to confirm 
their distribution and to determine correct statistical tests 
according to these results.
Outcomes will be analysed using mixed linear and 
logistic regression models considering participants as a 
random effect and group of treatment as fixed factors. 
Baseline characteristics will be introduced in the model 
as covariance. Numbers needed to treat index will also 
be calculated. The primary aim of the analysis will be to 
calculate the difference obtained in the VISA- P score after 
the intervention (final measurement - initial measure-
ment). Finally, the magnitude of the effect of the result 
will be calculated and therefore its clinical importance, by 
means of the following formula:
 
r =
√
F
(
1,dfR
)
F
(
1,dfR
)
+dfR  
where r= Pearson's effect size correlation, F= F test value, 
dfR= degree of freedom for F test value.
The significance level set for all the analysis will be 
p≤0.05.
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EthICs And dIssEMInAtIon
The study design, procedures and informed consent proce-
dure were approved and consequently the study will be 
carried out in compliance with the Helsinki Declaration 
of Human Rights. All participants will have to provide 
written Spanish informed consent (online supplementary 
appendix 1).
The results for this trial will be published in peer- reviewed 
international journals or otherwise made publicly available 
and will be presented at national and international confer-
ences and symposiums irrespective of the outcomes.
Any modifications to the protocol, which may impact 
the study procedures, potential patient benefits or may 
affect patient safety, including changes of study objec-
tives, study design, patient population, sample sizes, 
study procedures or significant administrative aspects 
will require a formal amendment to the protocol. Such 
amendments will be approved by the Ethics Committee 
prior to implementation and notified to the health 
authorities in accordance with local regulations.
All study- related information will be stored securely at 
the study site. All participant information will be stored 
in locked file cabinets in areas with limited access. All 
records that contain names or other personal identifiers, 
such as locator forms and informed consent forms, will be 
stored identified by code number. All local databases will 
be secured with password- protected access systems.
Availability of data and material
The data sets used and/or analysed during the current 
study are available from the corresponding author on 
reasonable request.
dIsCussIon
This study seeks to investigate the effects of physiotherapy 
needling techniques on pain, functionality and quality of 
life in PT.
PT is a common cause of knee pain in cases of degen-
eration of the patellar tendon. Among the causes of 
PT, extrinsic factors (eg, patellar tendon loading with 
exercise) and intrinsic factors (eg, malalignment, high 
patella, imbalances) have been proposed.30 Traditionally, 
the focus has been on quadriceps strengthening exercises 
and many reviews have shown that the effect of the treat-
ment could be estimated to give the patients a 50% to 70% 
change of improvement on pain and functionality.6 31 32
Regarding needling treatment, previous studies have 
shown a great improvement in PT using PNE in combina-
tion with EE, with all patients reporting an improvement 
at least 1 month after treatment.12–14 18 This is an improve-
ment compared with the minimum 3 months needed 
to improve symptoms by applying other conventional 
techniques (pharmacological and biological treatments, 
cold/heat techniques, shock waves, etc). Additionally, 
in a long- term study conducted in 2013, this technique 
was shown to improve symptoms quickly and steadily for 
at least 10 years.33 These findings demonstrate that this 
technique ensures that patients remain pain- free for a 
long period. Furthermore, we were only able to find four 
articles12–14 18 addressing the application of PNE for the 
recovery of PT, however, none of the articles studied were 
randomised controlled trials (RCTs), which entail limited 
evidence of the effectiveness of this technique.
In addition, there are no standardised protocols for the 
application of PNE, which explains the great variability in 
the number of sessions and application time based on the 
literature. Therefore, this study aims to facilitate clinical 
practice and combine the available methodology criteria 
in the application of this promising technique.
Regarding DN, the literature shows many similarities 
with PNE, since there is only one RCT that compares 
functionality improvements among patients who have 
received PRP. This study reflected that in the short- term 
PRP had better results for pain and functionality, however, 
DN was more effective than PRP after 6 months.34
For the application of both needling techniques, 
US- guidance is normally used to be able to observe first 
the presentation of the tendon, and later to observe 
the needle and enable a much more specific treatment 
approach. However, US has disadvantages including 
its operator dependence and the limited ability to rule 
out intra- articular disease. The sensitivity and specificity 
of ultrasonography for PT is between 58% and 94%, 
respectively.35
Moreover, functionality of the tendon is usually 
measured with the VISA- P,36 37 whereas jump tests (repre-
senting a similar action to that performed in subject’s 
daily sports) are only evaluated in a few papers.27 38 Coun-
termovement jumps and squat jumps are the most reliable 
and valid field tests for the estimation of the explosive 
power of the lower limbs in physically active men.39 Thus, 
we will combine both, in order to be more accurate in the 
assessment of the tendon's functionality, and be able to 
assess changes that may affect their sport performance.
This study has several strengths. First, we will eval-
uate two techniques that currently lack strong evidence. 
However, in doing so, we are contributing to new knowl-
edge in the field of the recovery of musculoskeletal 
injuries. Second, the role of invasive techniques will be 
determined by comparing the effects between these 
techniques and a control group. The reliability of data is 
ensured, as both patients and the assessor will be blinded. 
Third, a subanalysis with US will be performed to inves-
tigate changes in the presence of calcifications, cortical 
irregularities, neovascularisation, thickness, eco- intensity, 
eco- variation and eco- texture of the patellar tendon.
However, there are some limitations to this study. 
Blinding of the physiotherapist performing the interven-
tion is not possible. Furthermore, follow- up is limited to 
22 weeks after baseline.
The findings obtained may help advance the treatment 
of this injury by identifying the most effective treatment 
protocol and to avoid the associated consequences, such 
as the prevention of relapses and reducing the potential 
impact on the musculoskeletal system.
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